Filing Details

Accession Number:
0000899243-22-038565
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-15 06:55:39
Reporting Period:
2022-03-16
Accepted Time:
2022-12-15 06:55:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
730272 Repligen Corp RGEN Biological Products, (No Disgnostic Substances) (2836) 042729386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1696776 Carrie Manner Eglinton C/O Repligen Corporation
41 Seyon St., Bldg 1, Ste 100
Waltham MA 02453
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-16 625 $175.02 2,106 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct